Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Pain Self-Management and Treatment Engagement for Patients Taking Opioids

NCT06855732 · View on ClinicalTrials.gov ↗

Study Summary

The goal of this study is to learn if Pain Self-Management (PSM) can improve chronic pain care in individuals with opioid misuse or opioid use disorder (OUD) The main questions it aims to answer are: * Does PSM help participants manage their chronic pain more effectively? * Does PSM help participants engage in treatment for opioid use? Researchers will compare PSM to standard care to see if PSM is effective in managing chronic pain and engagement in treatment. Participants will: * Take part in the PSM program or receive standard care for 12 weeks after enrolling in the study * Complete surveys every 3 months for 9 months (total of 4 visits) Participants will receive compensation for participating in the study. There are risks associated with participating in the study, including breach of confidentiality and psychological distress caused by discussing difficult topics.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Pain Self-Management

Study Locations (16)

Pennsylvania

  • Renaissance Family Practice - Hampton Office — Allison Park
  • Renaissance Family Practice - RIDC Office — Blawnox
  • Renaissance Family Practice - Glenshaw Office — Glenshaw
  • Renaissance Family Practice - Millvale Office — Pittsburgh
  • Community Medicine, Inc. — Pittsburgh
  • UPMC General Internal Medicine-Montefiore — Pittsburgh
  • Renaissance Family Practice - Aspinwall Office — Pittsburgh
  • UPMC General Internal Medicine-Shadyside (Shea Medical Center) — Pittsburgh
  • Renaissance Family Practice - Harmarville Office — Pittsburgh
  • UPMC General Internal Medicine-Turtle Creek — Turtle Creek
  • Renaissance Family Practice - Penn Hills Office — Verona
  • UPMC General Internal Medicine-South — West Mifflin

West Virginia

  • St. Joseph's Rural Health Clinic (WVU Medicine) — Buckhannon
  • Harpers Ferry Family Medicine (WVU Medicine) — Harpers Ferry
  • WVU Medicine University Town Centre — Morgantown
  • WVU Medicine Primary Care — Shepherdstown

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2024-11-25
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Pittsburgh

1,082 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06855732

The ClinicalTrials.gov registry entry for NCT06855732 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,082 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions — of which Usual Care is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06855732 reports 16 study locations spanning 2 distinct geographic areas — top geographies include Pennsylvania, West Virginia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06855732 about?

NCT06855732 is a clinical study titled "Pain Self-Management and Treatment Engagement for Patients Taking Opioids". The goal of this study is to learn if Pain Self-Management (PSM) can improve chronic pain care in individuals with opioid misuse or opioid use disorder (OUD) The main questions it aims to answer are: * Does PSM help participants manage their chronic pain more effectively? * Does PSM help participan...

What is the current status of trial NCT06855732?

This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2024-11-25. Estimated completion is 2026-12-31.

What conditions does trial NCT06855732 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder, Opioid Misuse and Addiction. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06855732?

The interventions under investigation include: Usual Care (BEHAVIORAL), Pain Self-Management (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06855732?

This trial is sponsored by University of Pittsburgh, which has 1,082 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06855732 being conducted?

This trial has 16 study locations across Pennsylvania, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial